Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 1999, p. 2863-2871, Vol. 37, No. 9
Hepatitis Branch,
Received 9 December 1998/Returned for modification 13 April
1999/Accepted 16 June 1999
The antigenic composition of the hepatitis E virus (HEV) protein
encoded by open reading frame 2 (ORF2) was determined by using
synthetic peptides. Three sets of overlapping 18-, 25-, and 30-mer
peptides, with each set spanning the entire ORF2 protein of the HEV
Burma strain, were synthesized. All synthetic peptides were tested by
enzyme immunoassay against a panel of 32 anti-HEV-positive serum
specimens obtained from acutely HEV-infected persons. Six antigenic
domains within the ORF2 protein were identified. Domains 1 and 6 located at the N and C termini of the ORF2 protein, respectively, contain strong immunoglobulin G (IgG) and IgM antigenic epitopes that
can be efficiently modeled with peptides of different sizes. In
contrast, antigenic epitopes identified within the two central domains
(3 and 4) were modeled more efficiently with 30-mer peptides than with
either 18- or 25-mers. Domain 2 located at amino acids (aa) 143 to 222 was modeled best with 25-mer peptides. A few 30-mer synthetic peptides
derived from domain 5 identified at aa 490 to 579 demonstrated strong
IgM antigenic reactivity. Several 30-mer synthetic peptides derived
from domains 1, 4, and 6 immunoreacted with IgG or IgM with more than
70% of anti-HEV-positive serum specimens. Thus, the results of this
study demonstrate the existence of six diagnostically relevant
antigenic domains within the HEV ORF2 protein.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Antigenic Domains of the Open Reading Frame
2-Encoded Protein of Hepatitis E Virus
*
Corresponding author. Mailing address: Hepatitis
Branch, MS A-33, Division of Viral and Rickettsial Diseases, National
Center for Infectious Diseases, Centers for Disease Control and
Prevention, 1600 Clifton Rd. NE, Atlanta, GA 30333. Phone: (404)
639-2335. Fax: (404) 639-1563. E-mail: yek0{at}cdc.gov.
Journal of Clinical Microbiology, September 1999, p. 2863-2871, Vol. 37, No. 9
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|